MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Therapeutic Vision, Inc.

Therapeutic Vision has developed Kinostat for treating vision loss in diabetic dogs. In an FDA trial, Kinostat treated dogs were 85% and 84% less likely to develop cataracts and dry eye, respectively vs placebo. Compassionate use shows it safely preserved vision for 8 years. We have provisional approval to market Kinostat pending CMC submission and a bridging study. This drug class also beneficially reduces dry eye and promotes corneal healing in diabetic humans, safely allowing LASIK surgery.
Therapeutic Vision’s Kinostat brings a new paradigm to the clinical treatment of vision loss in diabetic dogs by directly blocking cataract

Connect with Therapeutic Vision, Inc.

Therapeutic Vision, Inc.

2021

2021 Finalist BOS-96

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.